Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.
Clinical trial NCT02049450 · COMPLETED
Trial details
- NCT number
- NCT02049450
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-28
- Primary completion
- 2016-04-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.